RALEIGH, N.C., Aug. 21, 2017 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq:INCR), the only fully-integrated biopharmaceutical solutions organization, today announced that Chief Financial Officer Greg Rush is scheduled to present at two upcoming investor conferences.
Mr. Rush is scheduled to present during the 2017 Wells Fargo Healthcare Conference in Boston, MA, on Wednesday, September 6, 2017, at 8:30 a.m. EDT.
Mr. Rush is scheduled to present during the 2017 Robert W. Baird Global Healthcare Conference in New York, NY, on Thursday, September 7, 2017, at 2:00 p.m. EDT.
Links to INC/inVentiv’s live presentation and archived audio replay, as well as the presentation materials, will be available via the Company’s Investor Relations website at investor.incresearch.com.
About INC Research/inVentiv Health
INC Research/inVentiv Health (Nasdaq:INCR) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to address new market realities where clinical and commercial share expertise, data and insights to accelerate biopharmaceutical performance. With more than 22,000 employees and the ability to support customers in more than 110 countries, our global scale and deep therapeutic alignment enables INC Research/inVentiv Health to help customers successfully navigate an increasingly complex environment. For more information on our Raleigh, N.C.-based company, visit incresearch.com or inventivhealth.com.
CONTACT: Investor Relations Contact: Ronnie Speight Vice President, Investor Relations +1 919 745 2745 firstname.lastname@example.org Press/Media Contact: Danielle DeForge Senior Director, External Communications +1 781 425 2624 email@example.com
News Provided by GlobeNewswire
© 2017 GlobeNewswire, Inc. All Rights Reserved